Evidence map›Paper›PMID 19348695›Full record

ArticleGenome medicine2009

Race and ancestry in biomedical research: exploring the challenges.

Timothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, Laura Arbour, Esteban G Burchard, Richard S Cooper, Billie-Jo Hardy, Simrat Harry, Robyn Hyde-Lay, Jonathan Kahn and 11 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Reporting and Analyzing Race and Ethnicity in Orthopaedic Clinical Trials: A Systematic Review.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2021
    Pooled it
  3. Pooled it
  4. A data model for population descriptors in genomic research.American journal of human genetics · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Review
  17. Article
  18. Diversity's Pandemic Distractions.Health matrix (Cleveland, Ohio : 1991) · 2022
    Article
  19. Article
  20. Leveraging genetic ancestry to study health disparities.American journal of physical anthropology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 17 institutions in 4 countries.

Timothy CaulfieldFaculty of Law and School of Public Health Research, Health Law Institute, University of Alberta, 89 Ave and 111 St., T6G 2H5, Canada.
Stephanie M Fullerton
Sarah E Ali-Khan
Laura Arbour
Esteban G Burchard
Richard S Cooper
Billie-Jo Hardy
Simrat Harry
Robyn Hyde-Lay
Jonathan Kahn
Rick Kittles
Barbara A Koenig
Sandra Sj Lee
Michael Malinowski
Vardit Ravitsky
Pamela Sankar
Stephen W Scherer
Béatrice Séguin
Darren Shickle
Guilherme Suarez-Kurtz
Abdallah S Daar
University Health Network · CAUniversity of Alberta · CAUniversity of Pennsylvania · USUniversity of Toronto · CAGenome Canada · CAHamline University · USInstituto Nacional do Câncer · BRLouisiana State University · USLoyola University Chicago · USMayo Clinic · USSickKids Foundation · CAStanford University · USUniversity of British Columbia · CAUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Leeds · GBUniversity of Washington · US

Funding

Translating Addiction Genomics Research into Practice: Examining Ethics & PolicyR01DA014577 · NIDA · STANFORD UNIVERSITY · PI MCCORMICK, JENNIFER BLAIR · 2002 to 2010
$2.0M
NIDA NIH HHS R01 DA014577
6 · The paper itself

Abstract

The use of race in biomedical research has, for decades, been a source of social controversy. However, recent events, such as the adoption of racially targeted pharmaceuticals, have raised the profile of the race issue. In addition, we are entering an era in which genomic research is increasingly focused on the nature and extent of human genetic variation, often examined by population, which leads to heightened potential for misunderstandings or misuse of terms concerning genetic variation and race. Here, we draw together the perspectives of participants in a recent interdisciplinary workshop on ancestry and health in medicine in order to explore the use of race in research issue from the vantage point of a variety of disciplines. We review the nature of the race controversy in the context of biomedical research and highlight several challenges to policy action, including restrictions resulting from commercial or regulatory considerations, the difficulty in presenting precise terminology in the media, and drifting or ambiguous definitions of key terms.

Identifiers

PMID19348695
PMCPMC2651580
OpenAlexW2159208695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.